While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

Among the various treatment strategies, the use of specialized emollients plays a crucial role in maintaining skin hydration and barrier function. Atopic dermatitis is a prevalent condition in ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to ...

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

ChatGPT recommendations regarding atopic dermatitis (AD) often differ from AAAAI/ACAAI practice parameter recommendations.

Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23 in JAMA ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

Findings seen through 76 weeks of treatment for adolescents taking 15- or 30mg doses for moderate to severe atopic dermatitis. HealthDay News — Long-term treatment of adolescents with moderate ...